256 Newsroom — Uganda's Digital News Infrastructure
Business

In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment - STAT

Published by STAT By Allison DeAngelis · 10 August 2026 at 18:13
Share
In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment - STAT
Image · STAT

What the report says

The FDA has rejected a radiopharmaceutical therapy because of manufacturing issues, halting what would have been a competitor for Novartis.

Read the full report at STAT →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Kataleya & Kandle reveal truth behind ‘gifted’ BMWSqoop Uganda 256 Newsroom JACKIE TAHAKANIZIBWA: ESG works best when it becomes everyone’s business - PML DailyPML Daily Four years of SafeCar: How SafeBoda listened to Ugandans and changed car hailingThe Independent Uganda 256 Newsroom Gov’t plans to offer health insurance to elderly people - Daily MonitorDaily Monitor 256 Newsroom Uganda Marketing Excellence Awards to Mark 6 years of innovation, Sustainability and Excellence This December - ChimpReportsChimpReports Digital Hubs Must Equip Youth for Jobs,says PS ZaweddeNile Post